Oppenheimer Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,462
Closed -$238K 1166
2024
Q2
$238K Hold
10,462
﹤0.01% 1033
2024
Q1
$318K Buy
10,462
+1,562
+18% +$52.3K ﹤0.01% 946
2023
Q4
$318K Sell
8,900
-570
-6% -$21.2K ﹤0.01% 973
2023
Q3
$415K Sell
9,470
-68
-0.7% -$3.32K 0.01% 892
2023
Q2
$471K Sell
9,538
-226
-2% -$10.4K 0.01% 876
2023
Q1
$405K Buy
9,764
+514
+6% +$21.3K 0.01% 895
2022
Q4
$411K Sell
9,250
-1,891
-17% -$79K 0.01% 901
2022
Q3
$436K Sell
11,141
-65
-0.6% -$2.97K 0.01% 862
2022
Q2
$458K Sell
11,206
-346
-3% -$16.4K 0.01% 878
2022
Q1
$759K Sell
11,552
-84
-0.7% -$5.44K 0.01% 823
2021
Q4
$809K Sell
11,636
-353
-3% -$25.7K 0.01% 841
2021
Q3
$834K Sell
11,989
-467
-4% -$35.9K 0.01% 799
2021
Q2
$988K Sell
12,456
-305
-2% -$22.2K 0.01% 758
2021
Q1
$836K Sell
12,761
-162
-1% -$9.98K 0.01% 772
2020
Q4
$719K Buy
12,923
+4,220
+48% +$182K 0.01% 786
2020
Q3
$347K Sell
8,703
-102
-1% -$4.33K 0.01% 903
2020
Q2
$396K Buy
8,805
+6,853
+351% +$298K 0.01% 848
2020
Q1
$66K Sell
1,952
-139
-7% -$5K ﹤0.01% 1202
2019
Q4
$68K Buy
2,091
+502
+32% +$14.3K ﹤0.01% 1282
2019
Q3
$40K Sell
1,589
-8
-0.5% -$228 ﹤0.01% 1377
2019
Q2
$48K Buy
1,597
+853
+115% +$24.9K ﹤0.01% 1378
2019
Q1
$20K Buy
744
+39
+6% +$1.19K ﹤0.01% 1455
2018
Q4
$22K Buy
+705
New +$22K ﹤0.01% 1456

Other funds holding ATRC

Oppenheimer Asset Management's ATRC Position: Q3 2024 in Review

Oppenheimer Asset Management sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 10,462 shares — an estimated $238K sold.

Oppenheimer Asset Management first reported a position in ATRC in Q4 2018 and held it in 23 quarters. The position peaked at $988K in Q2 2021. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • Oppenheimer Asset Management reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
  • Oppenheimer Asset Management sold 10,462 AtriCure shares in Q3 2024, an estimated $238K.
  • Oppenheimer Asset Management first reported a position in AtriCure in Q4 2018 and held it in 23 quarters.
  • Oppenheimer Asset Management's AtriCure position peaked at $988K in Q2 2021.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Oppenheimer Asset Management's 13F filing for Q3 2024, filed 5 Nov 2024.